Administration of benzodiazepine compositions

The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.

MEDICAL OR VETERINARY SCIENCE; HYGIENE

Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient-Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite-Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 

Medicinal preparations containing organic active ingredients-Heterocyclic compounds-having oxygen as the only ring hetero atom, e.g. fungichromin-having six-membered rings with one oxygen as the only ring hetero atom-condensed with carbocyclic rings, e.g. methantheline  -3,4-Dihydrobenzopyrans, e.g. chroman, catechin-Tocopherols, e.g. vitamin E

Medicinal preparations characterised by special physical form -Solutions 

Medicinal preparations characterised by special physical form -Dispersions; Emulsions 

Drugs for disorders of the nervous system-Antiepileptics; Anticonvulsants

SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

Medicinal preparations containing organic active ingredients-Heterocyclic compounds-having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins-having seven-membered rings, e.g. azelastine, pentylenetetrazole-having two nitrogen atoms, e.g. dilazep-1,4-Benzodiazepines, e.g. diazepam ; or clozapine

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00-Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient-Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite-containing oxygen, ; e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides-Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Medicinal preparations characterised by special physical form -Galenical forms characterised by the site of application-Nose

Medicinal preparations characterised by special physical form -Galenical forms characterised by the site of application-Pulmonary tract; Aromatherapy-Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy; -comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]

Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient-Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite-Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Prosecution History analysis

Examiner Search analysis

Invalidity Framework analysis

General

Analytics

Cases

Patent Assignments

Citations